Is tucatinib (tucatinib) available in China? Latest listing progress and purchasing methods

As of now, Tucatinib (Tucatinib), as a targeted therapy, has not yet been approved for marketing in China. Tucatinib is mainly used to treat HER2-positive breast cancer, especially in patients who are resistant to standard treatments. However, because the drug has not yet been launched in the Chinese market, patients cannot purchase it domestically through formal channels. For patients who need this drug, they may need to obtain it through overseas purchasing agents or imported drug channels.

Since the original drug tucatinib has not yet been launched in China, it cannot be reimbursed through medical insurance. According to price information in the international market, the price of the European version of tucatinib is very expensive. Taking the specification of 150mg*84 tablets as an example, each box is priced at more than 40,000 yuan. For ordinary patients, this price is undoubtedly a huge financial burden. In addition, due to the patent protection of drugs, original drugs are usually priced higher, further increasing the cost of treatment for patients.

Although the original drug of tucatinib is more expensive, multiple generic versions have been launched in overseas markets, and the price is relatively more affordable. For example, the generic version of tucatinib produced by a Lao pharmaceutical factory has a specification of 150mg*60 tablets and costs about more than 2,000 yuan. Compared with the original drug, this price is undoubtedly more economical and affordable. It is worth noting that generic drugs are basically the same as the original drugs in terms of drug ingredients and therapeutic effects. Therefore, patients can consider choosing generic drugs to reduce treatment costs, provided that the reliability of the purchase channel and the quality of the drugs are ensured.

Since tucatinib is not currently on the market in China, patients can only purchase the drug through imported drug channels or overseas purchasing. Patients need to choose purchasing channels carefully to ensure that the source of medicines is legal and guaranteed. With the launch of generic drugs, patients can also choose to purchase more affordable generic versions, especially in countries such as India and Laos, where the prices of generic drugs are relatively low. In addition, patients should consult with a medical professional to ensure they choose a treatment plan that is right for them and to understand how the medication is used and potential side effects.

Reference materials:https://www.tukysa.com/